
51 - 200 employees
Founded 2020
π₯ Healthcare
𧬠Biotechnology
π Pharmaceuticals
π° $100M Post-IPO Equity on 2022-12
Healthcare β’ Biotechnology β’ Pharmaceuticals
Erasca, Inc. is a clinical-stage precision oncology company committed to eradicating cancer by targeting one of cancer's most commonly mutated pathways, the RAS/MAPK pathway. The company is dedicated to developing a modality-agnostic portfolio of therapeutic programs designed to thoroughly shut down the RAS/MAPK pathway, which affects millions of lives globally each year. Erasca is advancing a robust pipeline with the potential to transform cancer treatment and improve the lives of patients suffering from various types of cancer. With a focus on groundbreaking science in oncology, Erasca aims to bring new hope to patients and lead the way in precision oncology innovations.
π September 24
πΊπΈ United States β Remote
π΅ $390k - $435k / year
β° Full Time
π Senior
π΄ Lead
β¨ SVP
π» Ghost score 6%
Where this job comes from
Posted on Erasca, Inc.'s careers page β, not through a job board
First seen by Remote Rocketship September 24
Still open on Erasca, Inc.'s site. Checked 8 hours ago.

51 - 200 employees
Founded 2020
π₯ Healthcare
𧬠Biotechnology
π Pharmaceuticals
π° $100M Post-IPO Equity on 2022-12
Healthcare β’ Biotechnology β’ Pharmaceuticals
Erasca, Inc. is a clinical-stage precision oncology company committed to eradicating cancer by targeting one of cancer's most commonly mutated pathways, the RAS/MAPK pathway. The company is dedicated to developing a modality-agnostic portfolio of therapeutic programs designed to thoroughly shut down the RAS/MAPK pathway, which affects millions of lives globally each year. Erasca is advancing a robust pipeline with the potential to transform cancer treatment and improve the lives of patients suffering from various types of cancer. With a focus on groundbreaking science in oncology, Erasca aims to bring new hope to patients and lead the way in precision oncology innovations.
β’ Provide medical leadership and oversight for pancreatic and colorectal cancer development programs β’ Collaborate with the Chief Medical Officer across the Erasca portfolio β’ Lead the clinical development subteam for all GI cancer studies β’ Design and implement novel, efficient clinical trials and assess appropriate endpoints β’ Lead clinical study subteams and monitor study integrity β’ Review, interpret, and communicate safety and efficacy data β’ Develop registrational strategies and contribute to regulatory filings and health authority interactions β’ Author clinical sections for INDs, NDAs, and related documents β’ Serve as medical lead and/or medical monitor on clinical programs and individual studies β’ Partner with Drug Safety to assess compound safety profiles β’ Author or support medical aspects of clinical research plans, protocols, investigator brochures, clinical study reports, and regulatory submissions β’ Contribute to scientific publications and author manuscripts β’ Present at scientific, medical, and regulatory meetings β’ Maintain clinical and scientific expertise through literature review and engagement with thought leaders, investigators, stakeholders, and partners β’ Participate in due diligence and business development activities β’ Hire, develop, and mentor medical directors and clinical scientists β’ Establish and maintain relationships across Erasca, particularly with Research and Development partners and stakeholders β’ Perform duties in accordance with company values, policies, and applicable regulations
β’ M.D. degree or equivalent, with subspecialty fellowship training and board certification or eligibility in Oncology or Oncology/Hematology required β’ 8-10+ years of oncology clinical trial and drug development experience, including extensive experience in the pharmaceutical or biotechnology industry β’ Experience as the clinical lead on late-stage clinical programs in colorectal, pancreatic, or other GI cancers required β’ Experience leading or being closely involved in the clinical aspects of a regulatory filing and direct interaction with health authorities required β’ Exposure to early development and the transition from FIH to registrational trials preferred β’ Extensive knowledge of clinical trial methodology and regulatory and compliance requirements governing clinical trials β’ Demonstrated ability to collaborate successfully with multiple functions in a matrixed team environment β’ Executive leadership skills to educate and influence stakeholders and contribute to strategic business planning and decision-making β’ Effective interpersonal, communication, influencing, and excellent writing skills β’ Ability to achieve high performance goals and meet deadlines in a fast-paced environment β’ Strong learning orientation, curiosity, and commitment to science and patients
β’ Annual bonus β’ Equity grant at hire and annually in the form of an option to purchase stock in the future for a specified price β’ Paid Time Off β’ Holiday and Sick Leave β’ Medical, Dental and Vision Plans β’ Short- and Long-Term Disability β’ Basic and Voluntary Life/AD&D Coverage β’ Flexible Spending Accounts (FSA, HSA, and Commute) β’ Critical Illness and Accident Coverage β’ Pet Insurance β’ Employee Assistance Program β’ 401(k) Plan with Erasca contribution β’ Employee Stock Purchase Program β’ Casual, collaborative, and fun work environment
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π September 18
Senior health plan executive scaling Leapβs employer specialty pharmacy partnerships. Leading strategy, complex deals, partner expansion, and a high-performing sales team.
πΊπΈ United States β Remote
π΅ $225k - $300k / year
π° $1M Venture Round - LEAP HEALTH on 2024-03
β° Full Time
π΄ Lead
β¨ SVP
π¦ H1B Visa Sponsor
π September 14
SVP Product defining AI strategy, portfolio, and operating model for Toptal, a global talent network. Leading product organization, hiring, and AI-enabled platform execution.
π September 11
SVP leading Sinch Mailgun, Sinchβs API-first email platform, across product, engineering, strategy, and P&L. Integrating email into Sinch Build while driving enterprise growth, reliability, and customer adoption.
πΊπΈ United States β Remote
π΅ $252.8k - $316k / year
π° $48.8M Post-IPO Debt - Sinch on 2024-09
β° Full Time
π΄ Lead
β¨ SVP
π¦ H1B Visa Sponsor
π September 10
SVP, Product leading Product, Design, and AI Enablement at Axios, a clarity-focused media company. Establishing a scalable operating model for AI-enabled products and workflows.
πΊπΈ United States β Remote
π΅ $285k - $315k / year
β° Full Time
π΄ Lead
β¨ SVP
π¦ H1B Visa Sponsor
π September 8
SVP leading integrated media planning, client strategy, and team development for BarkleyOKRP and MissionOne Media. Driving account growth, new business, and differentiated media thinking.